AddLife AB (publ)
Research AddLife AB (publ) (ALIF-B) on Bullrun: valuation model: fairly valued, market cap SEK 20.72B, P/E 36.5, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALIF-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Valuation signalfairly valued
- Market capSEK 20.72B
- P/E36.5
- Dividend yield0.9%
- Financial periodFY2024
- RevenueSEK 10.29B
- Revenue growth6.2%
- Net incomeSEK 254.00M
- Free cash flowSEK 845.00M
- Gross margin37.5%
Valuation Snapshot
Bullrun's latest valuation model marks AddLife AB (publ) as fairly valued; latest market cap is SEK 20.72B; P/E is 36.5; dividend yield is 0.9%.
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis.
Frequently asked questions
Is AddLife AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks AddLife AB (publ) as fairly valued.
What is AddLife AB (publ)'s market cap?
AddLife AB (publ)'s market capitalization is SEK 20.72B.
What is AddLife AB (publ)'s P/E ratio?
AddLife AB (publ)'s price-to-earnings (P/E) ratio is 36.5.
Does AddLife AB (publ) pay a dividend?
AddLife AB (publ) has a dividend yield of 0.9%.
What does AddLife AB (publ) do?
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech.